Lucid Diagnostics Inc.
LUCD- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001799011
No open-market purchases or sales by Lucid Diagnostics Inc. insiders were filed in the last 90 days; 115 institutions reported holding it in 13F filings for Q2 2026, worth $65.7M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Lucid Diagnostics Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 25 | 30 | +5 |
| Shares | 1.75M | 2.07M | +323.9K (+18.5%) |
| Value | $2.46M | $1.69M | −$775.4K (−31.5%) |
New holders (9)
Institutions that held Lucid Diagnostics Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 63,035 | $51.0K | 0.00% |
| Northern Trust Corp | 13,145 | $10.6K | 0.00% |
| Jones Financial Companies LLLP | 3,831 | $3.10K | 0.00% |
| CWM, LLC | 1,761 | $1.00K | 0.00% |
| CIBC Private Wealth Group, LLC | 315 | $283 | 0.00% |
| Allworth Financial LP | 157 | $128 | 0.00% |
| Newbridge Financial Services Group, Inc. | 50 | $40 | 0.00% |
| M&R Capital Management Inc | 25 | $20 | 0.00% |
| Thompson Investment Management, Inc. | 1 | $1 | 0.00% |
Sold out (4)
Institutions that held Lucid Diagnostics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Bridgeway Capital Management, LLC | 135,000 | $190.3K |
| Byrne Asset Management LLC | 6,610 | $9.52K |
| UBS Group AG | 5,708 | $8.05K |
| Advisory Services Network, LLC | 765 | $1.08K |